Clinical Outcomes And Visual Acuities Of Novel Full Range Of Vision Iol With First Ai Spiral Optic Design
Published 2025 - 43rd Congress of the ESCRS
Reference: FP32.06 | Type: Free paper | DOI: 10.82333/jbtq-qs59
Authors: Alf Clinton Nyström* 1 , Arzu Karatepe Hashas 1 , Jenny Gyllen 1 , Birgitte Haargaard 2 , Anna Linnarsson Wiklund 3 , Eric Trocme 4 , Ulrika Kjellström 5 , Kristina Tornqvist 5 , Gunilla Magnusson 1
1Department of ophthalmology,Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg,Gothenburg,Sweden, 2Private surgery,Copenhagen,Denmark, 3Department of Pediatric Ophthalmology and Strabismus,St Erik Eye Hospital,Stockholm,Sweden, 4Department of Clinical Neuroscience,Karolinska Institute, St Erik Eye Hospital,Stockholm,Sweden, 5Department of ophthalmology, SUS,Department of Clinical Sciences Lund University,Lund,Sweden
Purpose
This analysis aims to present the clinical visual acuity (VA) outcomes with the novel spiral full range of vision intraocular lens (IOL) designed with AI. A preclinical comparative evaluation with the Real Artificial Lens Vision (RALV) device (DEZIMAL GmbH, Vienna, Austria) suggests that the RayOne Galaxy spiral IOL can achieve visual acuity results similar to diffractive trifocal IOLs. This evaluation of a multicentre data collection shows real-world clinical binocular VA outcomes with the RayOne Galaxy IOL.
Setting
Multicentre data collection:
- OCL Vision, London, England
- ADVALIA Vision, Milano, Italy
- Department of Ophthalmology and Optometry at Medical University of Vienna, Vienna, Austria
- Department of Ophthalmology at University Eye Clinic Heidelberg, Germany
- Auckland Eye, Auckland, New Zealand
- Clínica Privada de Oftalmologia, Lisbon, Portugal
- Clinica Baviera Aier Group, Valencia, Spain
- Vision Scotland, Edinburgh, Scotland
- Rothschild Foundation Hospital, Paris, France
Methods
Preoperatively, we performed slit lamp examination, keratometry and biometry, as well as subjective refraction. The follow-up visits were scheduled for one month and three months postoperatively and uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) at 4 m, uncorrected intermediate visual acuity (UIVA) and distance corrected intermediate visual acuity DCIVA at 66 cm, uncorrected near visual acuity (UNVA) and distance corrected near visual acuity (DCNVA) at 40 cm were measured.
Results
At one month post op total of 91 patients (182 eyes) were operated, of which 57 patients were available for analysis at one month and 25 patients at three months follow-up. At 1 month and at 3 months post-op the binocular UDVA was 0.00±0.10 and -0.01±0.09, CDVA was -0.04±0.07 and -0.07±0.06 logMAR, respectively. The binocular UIVA was 0.01±0.10 and -0.04±0.1, DCIVA was 0.01±0.10 and 0.01±0.11, respectively. The binocular UNVA was 0.06±0.13 and 0.05±0.11, DCNVA was 0.05±0.13 and 0.05±0.14, respectively. Cumulatively 100% of patients achieved a binocular VA of 0.2 logMAR or better for distance and intermediate vision with and without correction. At near 96% of patients achieved a VA of 0.2 logMAR or better with and without correction.
Conclusions
The binocular visual acuities showed excellent results for far intermediate and near distances. The results remained stable between the one month and three months follow-ups. The results demonstrate that the novel full range of vision IOL featuring a unique spiral design provides a high visual acuity at various distances. These findings may suggest that patients can reach a high level of spectacle independent vision similar to what we achieve with diffractive trifocal IOLs.